Novartis acquires Japanese generics business in €400m deal
Novartis has agreed to buy the Japanese business of South African generics manufacturer Aspen Pharmacare for a potential €400 million.
UK biotech industry publishes manifesto ahead of UK election
The UK BioIndustry Association has published a manifesto detailing its recommendations on how political parties can support innovation in the UK life sciences sector, ahead of the UK general election.
AstraZeneca announces new R&D, AI centres in China
AstraZeneca is planning to build a new global research and development centre in China.
23andMe petitions Fed Circuit for en banc review
DNA testing and analysis company 23andMe has asked the full US Court of Appeals for the Federal Circuit to review an earlier panel decision which held that one of its patents is invalid.
US government sues Gilead for patent infringement over HIV drugs
The US government is suing Gilead for patent infringement, claiming that the pharmaceutical company has been piggybacking on public research to earn billions from its HIV drugs.
Second Circuit dismisses antitrust claims against Roche
The US Court of Appeals for the Second Circuit has dismissed a Russian pharmaceutical company’s antitrust claims against Roche.
Pfizer and Sun settle Bosulif dispute
Pfizer and Indian drugmaker Sun Pharmaceuticals have agreed to settle patent litigation over a generic version of Pfizer’s leukaemia drug, Bosulif.
Takeda sells generics portfolio to Stada for $660m
German pharmaceutical company Stada Arzneimittel has acquired a portfolio of products from Takeda for $660 million.
USITC begins Olympus patent probe
The US International Trade Commission is investigating certain endoscopic devices after a German medical devices company accused Japanese optical products manufacturer Olympus of patent infringement.
Donald Trump to nominate Stephen Hahn as FDA commissioner
US President Donald Trump has nominated a new commissioner of the Food and Drug Administration.
